Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.



Gencell was the gene therapy division of RPR dedicated to the discovery, development and commercialization of cell and gene therapies.

Search Projects

  • Vice President, Clinical Research and Regulatory Affairs
  • Vice President, Worldwide Clinical Research
  • Director, Preclinical Development
  • Director, Medical Affairs
  • Associate Director, Clinical Research, Oncology
  • Associate Director, Biometrics
  • Director, Global Training and Development
  • Director, Oncology Gene Therapy